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CHAPTER 1 
General introduction 
 
Medicinal chemistry is a field involving the study of chemistry of medicinal 
mushrooms as well as medicinal herbs and their application in the field of 
pharmacology, in order to prepare novel drugs by biotechnological means. This field 
is becoming more important day by day, and has been widely investigated due to its 
practical benefits. Synthetic drugs are available in the commercial market and are 
being used in daily life, but they are not safe enough as they leave some side effects 
and sometimes harmful for human health. On the other hand, there is still a lack in 
research on the chemistry and bio-constituents of the medicinal mushrooms those 
may provide more efficacious and safer drugs having no side effects. This thesis 
intends to fill this lack, focusing on the production of anti-cancer agent from the 
natural source like medicinal mushroom Cordyceps militaris to be used in the realm 
of pharmaco-industrial biotechnology. 
 
1.1 Fundamentals of medicinal mushrooms 
 
Cordyceps genus is the name given to the fungi on insects, and its existence has 
been known since in the era, 2000 B.C. The medicinal mushrooms including 
Cordyceps species are abundant sources of useful natural products with various 
biological activities [1]. One of the most important traditional Chinese medicines, 
Cordyceps militaris (an entomopathogenic fungus; Fig. 1-1), which belongs to the 
class Ascomycetes, has been used extensively as a crude drug and a folk tonic food in 
East Asia [2]. It contains many kinds of active components (such as cordycepin, 
ergosterol, mannitol and, polysaccharides), and due to its various physiological 
activities, it is now used for multiple medicinal purposes [3-5]. In the wide meanings 
of fungi parasitic to the insects, more than 350 types have been discovered until now. 
At present, the detailed research about its elements is being done in universities and 
other research institutions, this has increased greatly its medicinal value. There are 
over 2,500 mushroom varieties grown in the world today. It is estimated that more 
than 10 million metric tons of edible and medicinal mushrooms were produced last 
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year in various countries [6]. That is why mushrooms have recently received 
significant attention from medical and pharmacological researchers as rich sources 
of biologically active compounds [7]. The taxonomical data of C. militaris and 
popular names of Cordyceps are given below: 
 
 
 
 
 
 
 
Fig. 1-1 Photograph of Cordyceps militaris (www.jscr.jp) 
 
Taxonomical data of Cordyceps militaris: 
 
 
 
 
 
 
 
 
 
 
Popular names of Cordyceps: 
 
Kingdom Fungi 
Phylum Ascomycota 
Sub-phylum Ascomycotina 
Class Ascomycetes/Pyrenomycetes
Order Hypocreales 
Family Clavicipataceae 
Genus Cordyceps 
Species Cordyceps militaris  
Common name Caterpillar fungus, Cordyceps, Cetepiller mushroom 
Latin/English name Cordyceps militaris, Cordyceps mushroom, Deer fungus, Caterpillar fungus
Chinese name Dong Chong Xia Cao, Summer grass-winter worm, Hia tsao tong tchong 
Japanese name Tochukaso/Tochukasu, Totsu kasu 
Korean name Tong ch'ug ha ch'o 
Nepali name Yarsagumba, Jeebanbuti, Sanjivani, Kiraghans 
Tibetian name Yarchakunbu 
Other names Chong cao, Dong chong cao, Aweto 
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1.2 Applications of medicinal mushrooms 
 
Cordyceps militaris is a potential harbour of bio-metabolites for many potential 
drugs and evidence is available about its applications for the revitalization of various 
systems of the body from ancient times. WHO estimated that about three-quarters of 
the world’s population currently use natural drugs and other forms of traditional 
medicines like medicinal mushrooms to treat their diseases [8] including asthma 
(24%) [9] breast cancer (12%) [10], HIV (22%) [11], liver disease (21%) [12], and 
rheumatological disorders (26%) [13]. Simultaneously, the development of modern 
chemistry permitted the isolation of chemicals from medicinal mushrooms that have 
served as drugs or starting materials for the synthesis of many important drugs used 
today. Many modern drugs have been synthesized based on the structures and action 
mechanisms of chemicals isolated from medicinal mushrooms [7]. Thus, medicinal 
mushrooms have played a major role in the development of modern medicine and 
continue to be widely used in their original form [14]. 
 
 
 
 
Cordycepin (3′-deoxyadenosine)                     Adenosine 
 
 
Fig. 1-2 Chemical structures of cordycepin and adenosine 
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Fig. 1-3 Inhibition of purine and polynucleotide biosynthesis by cordycepin 
 
The main active constituent of C. militaris fruiting bodies is cordycepin, which was 
first extracted from C. militaris and then found to be present in Cordyceps sinensis 
[15] and Cordyceps kyushuensis [16]. The cordycepin (3′-deoxyadenosine, 
C10H13N5O3, m.p. 225 °C, [α] D-47°) (Fig.1-2), a nucleoside analogue [15, 17], is 
considered as a nucleic acid antibiotic that might inhibit canceration of cells 
contributing to the normalization of cancer cells as one of the constituents of gene 
DNA [15]. In addition, it has been reported that the cordycepin is intracellularly 
converted into its 5′-mono-, di- and triposphates that inhibit the activity of several 
enzymes (Figs. 1-3) in the purine biosynthetic pathway [18]. The recent studies have 
demonstrated that the extracts of C. militaris have multiple pharmacological actions, 
such as inhibition of human glomerular mesangial cell proliferation [19], 
anti-fibrotic [20], anti-angiogenetic [21], improvement of insulin resistance and 
insulin secretion [22], anti-inflammatory [23], and growth inhibition of U937 
leukemia cells [24]. Besides, it is also reported that cordycepin itself acts as an 
anti-tumour, anti-proliferative, anti-metastatic, insecticidal and anti-bacterial 
compound [4]. Therefore, the medicinal mushroom C. militaris is one of the most 
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important candidates that may be used as the medicinal base in the future. 
 
1.3 Constraints and prospects of anti-cancer agent production from the 
medicinal mushroom Cordyceps militaris 
 
 As cancer remains the second leading cause of death in most of the countries, there 
is a need for effective medicinal compounds as its remedy. To synthesize and modify 
the structure of bioactive natural products is an effective approach to find some 
potential compounds with anti-cancer activity [25]. In the present state, the 
production of cordycepin from the fruiting body of Cordyceps militaris is not likely 
to reach commercial levels due to some practical limitations. For example, 
Cordyceps militaris is very scarce in nature due to the requirements of specific hosts 
and strict growth environments. On the other hand, it is necessary to note that the 
chemical synthesis of cordycepin requires a complicated process resulting a lower 
productivity, moreover, a large volume of organic solvents those are harmful 
substances to the environment may be discharged [26, 27]. The friendly production of 
cordycepin from the cultured mycelia of Cordyceps militaris in a large scale is 
currently an acute issue. Some experiments have already proven that the chemical 
components of natural and cultured Cordyceps militaris are similar [28, 29]. 
The ancient medicinal fungus C. militaris, which has been used as a crude drug 
for the welfare of mankind in old civilization, is now of a matter of concern due to 
its unexplored potentials. The anti-cancer agent cordycepin obtained from C. 
militaris have more than 21 clinically approved beneficial effects for human health. 
Especially, the anti-cancer agent cordycepin from C. militaris is expected to play 
evolutionary roles in the pharmacognosy sector, leading to create a viable base for 
pharmaceutical industries as some emerging diseases like CANCER, SARS, AIDS, 
SWINE FLU have no proper remedies yet.  
Considering these facts, mutation of C. militaris by a high-energy ion beam 
irradiation to have a new potential mutant, medium optimization, use of suitable 
additives, and repeated batch culture technique might be vital tools to allow the 
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production of anti-cancer agent cordycepin reach to the commercial levels.  
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CHAPTER 2 
A new approach for improving cordycepin productivity in surface 
liquid culture of Cordyceps militaris using high-energy ion beam 
irradiation  
 
2.1 Introduction  
 
Cordycepin, one of the most bioactive compounds found in Cordyceps species 
(summer grass-winter worm) exhibits anti-microbial, anti-tumor, anti-metastatic, 
immunomodulating and insecticidal effects [1, 2]. Various studies of cordycepin 
production using Cordyceps species have been carried out to meet its increasing 
demand [3, 4]. In the present state, the production of cordycepin is not likely to 
reach a commercial level owing to some practical limitations regarding production, 
and therefore, the mutation using a new technique will be expected to allow its 
production to reach a commercial level. 
Ion beams, among many mutation methods, are powerful and efficient mutagenic 
tools with high linear energy transfer (LET) radiation as they can generate mutations 
more frequently than low LET radiations such as electrons, X-rays and gamma rays 
[5], and the range of the ion beams on the target materials can be controlled [6]. 
Moreover, ion beams induce nuclear DNA alterations, such as inversion, 
translocation, transversion and large deletions rather than point mutations, and 
therefore, this random mutagenesis could produce various types of mutants [5, 7, 8]. 
There are some applications of low-energy ion implantation (keV) [9], but the 
penetration depth into a microorganism (~nm) is practically much lower than the 
MeV ion beam. Therefore, the probability that the keV ion beam reaches the nuclear 
DNA is much lower than that of the MeV ion beam. On the other hand, it is 
necessary to note that the chemical mutagenesis has potential health and 
environmental hazards. 
The application of high-energy (~MeV) ion beam irradiation has been limited for 
micro-organism mutagen, and therefore, an unknown but strong possibility for the 
mutagen could be expected. In this study, the high-energy proton beam irradiation 
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was applied to get Cordyceps militaris mutants that could produce cordycepin at 
commercial level. 
 
 
2.2 Materials and methods 
 
2.2.1 Characteristics of mutant induction by ion beam irradiation 
 
 Ion beam irradiation is applied to various fields such as material science, 
biotechnology and medical sciences. In principle, any irradiation system usually 
change in the genetic sequences of targeted material resulting a new one having 
higher or sometimes lower production capacity. The characteristics of mutation 
induction by different irradiation systems are somewhat different regarding their 
point of action. In fact, many investigators, chiefly using mammalian systems, have 
reported that relative biological effectiveness (RBE) of DNA damage, lethality, 
mutation etc. of ion beams is much higher than that of low LET ionizing radiation. 
Also, it is still unknown whether ion beams can induce peculiar mutants that have 
never been found by low LET radiations and chemical mutagens in plants. Fig. 2-1 
shows the comparative mutation induction types of gamma ray and ion beam 
irradiation.  
 
 
 
 
 
 
 
 
 
 
Fig. 2-1 Comparative mutation induction type of gamma ray and ion beam 
irradiation 
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2.2.2 Ion beam irradiation and screening 
 
2.2.2-1 Irradiation protocol by carbon and proton beam 
Cordyceps militaris NBRC 9787 (wild strain) used in the present experiments was 
purchased from the National Institute of Technology and Evaluation, Japan, and was 
stored at 5 °C as the control. It was inoculated on a PDA (Nissui Pharmaceutical Co., 
Ltd., Japan) plate with 3.5 cm diameter and incubated for 10 days at 25 °C. The 
carbon or proton beam irradiation to the plate culture was carried out using the 
Wakasa-wan Multi-purpose Accelerator with a tandem injector and a synchrotron 
(Hitachi, Ltd., Japan) at the Wakasa-wan Energy Research Center, Japan. Fig. 2-2 (a) 
is a photograph of the synchrotron accelerator, and Fig. 2-2 (b) is a schematic 
diagram of the ion beam irradiation apparatus for biological materials. The beam 
accelerated by a tandem injector and a synchrotron is transformed into an 
approximately 4 or 10 cm-square circle beam for the carbon and proton beam 
irradiations, respectively, with a uniform intensity distribution through the scatters, 
wobbler magnets and collimator. Fig. 2-2 (c) shows the irradiated areas of the carbon 
and proton beams, and the conditions for these irradiations are presented in Table 
2-1. 
 
Table 2-1 Characteristics of ion beam irradiations 
 
Ion beams 
Beam energy  
(MeV) 
LET  
(keV/μm) 
Penetration depth in water  
(mm) 
Dose  
(Gy) 
Carbon 660 42 9 200-2000  
Proton 200 0.5 250 100-1000  
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Fig. 2-2 (a) Synchrotron Accelerator at Wakasa-wan Multi-purpose Accelerator 
with Synchroton and Tandem (W-MAST); (b) Schematic diagram of ion beam 
irradiation apparatus for biological materials at W-MAST; (c) Ion beam 
irradiated areas of carbon and proton beams 
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2.2.2-2 Measuring the growth rate of irradiated strains  
For the growth rate measurement in a plate, a loop of mycelia from the center of 
the irradiated plate was inoculated on the center of a fresh 9 cm PDA plate and 
incubated at 25 °C. The maximum and minimum diameters of the mycelial zone of 
each plate were measured using a vernier caliper every 3 days. The data from the two 
irradiated plates were averaged and compared to that of the control. The same 
procedure was applied for both the carbon and proton beam irradiations. 
 
2.2.2-3 Selection of analogue (8-azaadenine or 8-azaguanine)-resistant mutants 
To get higher cordycepin production, the irradiate mutants were grown in the 
presence of the analogue 8-azaadenine and 8-azaguanine to have 8-azaadenine- and 
8-azaguanine-resistant mutants. Because, these mutants can remove the feedback 
inhibition cycle, and thus could increase the cordycepin production. The procedure 
followed in this experiment is described below: 
A quarter of the mycelia from the irradiated and selected plate was suspended in 5 
ml of physiological saline and filtered through double gauze and nylon mesh (250 
μm). The filtrate was diluted to a 1/10 concentration, and then spread on Vogel’s 
medium (using glucose instead of sucrose) agar plate supplemented with 200 mg/l of 
8-azaadenine or 8-azaguanine [10]. Colonies that appeared on the plate after 
incubation at 25 °C (incubation time varied case by case) were isolated, and the 
selected colony was inoculated on an agar slant composed of the same medium as 
the stock culture of the mutant that was stored as 5 °C. In this way, the analogue 
resistant mutants were selected in order to observe the effects of the feedback 
inhibition cycle on the cordycepin production. 
 
2.2.2-4 Evaluation of cordycepin production performance using anti-microbial test 
A Bacillus subtilis NBRC 3134 suspension with 1.5×105 cells/ml was prepared for 
the anti-microbial test. A 0.1 ml portion of its suspension was seeded on an agar 
plate with Spizizen’s minimum medium and 5 g/l casamino acids. Furthermore, an 8 
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mm disk was punched from the center of each plate on which the mutants and 
control strain of C. militaris had been cultured with the medium of the cordycepin 
production (the basal medium with 2 wt % agar in Table 2-2) for 30 days at 25 °C. 
Each disk from C. militaris was placed on the surface of the agar plate spread with B. 
subtilis and incubated for 24 h at 30 °C. The growth-inhibiting zone toward B. 
subtilis was compared between the mutant and control. The mutants having the more 
distinct and larger growth-inhibiting zone than the control were taken. 
 
2.2.3 Surface liquid culture of analogue-resistant mutants and control  
 
The stock culture for the control (C. militaris) was stored on a PDA slant at 5 °C. 
For the 8-azaadenine- or 8-azaguanine-resistant mutants, a Vogel’s medium agar 
slant supplemented with 8-azaadenine or 8-azaguanine was used for the stock culture 
and also stored at 5 °C. The active PDA slant from the stock culture for the mutant 
and control was prepared by culturing for 8 days at 25 °C, and then the seed culture 
transferred from the active slant was grown on a 9 cm PDA plate for 13 days for the 
control and the 8-azaadenine-resistant mutant, and 20 days for the 
8-azaguanine-resistant mutant at 25 °C. The inoculum was prepared by punching out 
1 cm of the PDA plate culture using a sterilized cylindrical cutter. The surface liquid 
culture was started by inoculating the seed disk into a 500 ml culture bottle, which 
had a 8.5 cm diameter and 14.0 cm height with a bottleneck whose diameter and 
height were 4.5 and 4.0 cm, respectively. The working volume of the surface liquid 
culture medium was 100 ml for each bottle, and the bottleneck was fitted with a 
cotton plug during the culture. The prepared bottles were placed in an incubator 
maintained at 25±1 °C. 
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A 1 ml portion of the medium was mainly sampled at 3 day intervals through the 
sampling port and filtered through a 0.45 μm membrane filter in order to remove the 
Table 2-2 Composition of basal and enriched medium 
    
       Concentration (g/l) 
Components  
Basal medium   Enriched medium 
Nitrogen sources    
  Peptone 2.5      0  
  Yeast extract 7.5 45  
    
Carbon source    
  Glucose 20 50  
    
Others (diluted to 1/10 concentration of Vogel's medium) 
       (Same for both basal and enriched medium)  
NaOC(COOH)(CH2COONa)2·2H2O 0.28  
KH2PO4 0.5  
NH4NO3 0.2  
MgSO4·7H2O 0.02  
CaCl2·2H2O 0.01  
Citric acid 0.46 × 10−3  
ZnSO4·7H2O 0.50 × 10−3  
Fe(NH4)2(SO4)2·6H2O 0.10 × 10−3  
CuSO4·5H2O 0.025 × 10−3  
H3BO3 5.0 × 10−6  
MnSO4·(4–5)H2O 5.0 × 10−6  
Na2MoO4·2H2O 5.0 × 10−6   
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suspended mycelia. Just before the sampling, the medium was gently agitated for 5 s 
by a magnetic stirrer. The filtrate was analyzed for cordycepin, glucose and pH. All 
experiments were carried out at least in duplicate, and the results were then averaged. 
The composition of basal [4] and enriched medium for the surface liquid culture is 
presented in Table 2-2. 
 
2.2.4 Analytical procedures 
 
The cordycepin concentration was determined by an HPLC (LC-9A system, 
Shimadzu Corp., Japan) under the following conditions: TSK-gel ODS-80Ts (Tosoh 
Corp., Japan); mobile phase, methanol and 0.1% phosphoric acid (2/98, v/v); flow 
rate, 1.0 ml/min; column temperature, 40 °C and peak detection, UV at 260 nm. The 
cordycepin concentration shown in this experiment was re-estimated by considering 
the condensation of the medium in the culture bottle due to vaporization.  
The glucose concentration was analyzed by the mutarotase-glucose oxidase 
method using the Glucose CII test Wako (Wako Pure Chemical Industries, Ltd., 
Japan). For the measurement of dry mycelia weight, at the end of each culture 
(glucose conc. <0.5 % of the initial concentration), the entire remaining content in 
the bottle was centrifuged at 16,000 g (10000 rpm) and 4 °C for 20 minutes. The 
precipitated mycelia were then sufficiently washed with distilled water, and dried at 
105 °C for 24 h to measure the dry mycelia weight. The pH of the collected samples 
was measured by a pH meter. 
 
2.3 Results and discussion 
 
2.3.1 Comparison of growth rate of carbon and proton beam irradiated strains 
with control 
 
Carbon beam irradiation to the plate culture of C. militaris with a dose range of 
200-2000 Gy revealed that the irradiation doses up to 750 Gy had very little growth, 
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but over 1000 Gy, there was no growth. In spite of that, screenings of the carbon 
beam irradiated strains have been carried out for verification, resulting in the 
acquisition of some 8-azaadenine resistant mutants, but they did not show a higher 
production of cordycepin compared to the control (data not shown). These results 
indicated that the carbon beam irradiation was not effective on C. militaris as a 
potential mutagen.  
  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-3 Time courses of the mycelial growth after 600 or 800 Gy proton beam 
irradiations 
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As DNA repairing after a break caused by ion beam irradiation affects the 
probability of inducing mutations, high LET carbon beam irradiation to Cordyceps 
militaris would cause dense spatial clustering of DNA damage, which might be 
difficult to repair [11]. These damages would become a significant impediment to the 
survival of the wild strain or mutants that might have lower cordycepin production. 
On the other hand, proton beam irradiation with relatively low LET would cause 
DNA damages to be capable of repairing and also there may be a higher degree of 
single gene mutation that occurs in the new mutant obtained by the proton beam 
irradiation than the carbon beam irradiation. In our preliminary experiment, it was 
revealed that the UV irradiation was not effective for cordycepin higher production.  
After application of the proton beam irradiation to the plate culture at doses of 200, 
400, 600 and 800 Gy, the growth rate of the irradiated strains were measured. The 
results of the irradiation doses of 200 and 400 Gy were almost the same level as that 
of the control (data not shown). Fig. 2-3 shows the time courses of the mycelial 
growth for the irradiation doses at 600 and 800 Gy. These results indicated that some 
of these, that included strain nos. 63, 81 and 82, were more significantly affected 
than the other irradiated strains. Therefore, these strains were selected for a 
subsequent screening. Hence, it was expected that a mutation might be induced in 
these strains whose growth rate was changed due to irradiation. It should be 
mentioned that the result of the irradiation at a dose below 200 Gy was like the 
control, while over 1000 Gy, was unsuccessful as there was no mycelial growth. 
 
2.3.2 Selection and isolation of mutants that show preferable an anti-microbial 
effect 
 
After successful irradiation by the proton beam, 30 classes of 8-azaadenine- and 
28 classes of 8-azaguanine-resistant mutants were obtained from strain nos. 63, 81 
and 82. As cordycepin inhibits the growth of B. subtilis [12], the B. subtilis growth 
inhibiting assays of 58 classes of analogue resistant mutants were performed to 
roughly estimate the capability of the cordycepin production. Of these, 4 mutants 
 19
(A63-7, A63-8, A81-2, A81-6) from the 8-azaadenine resistant mutants and 3 
mutants (G63-8, G81-3, G82-4) from the 8-azaguanine resistant mutants were 
promising cordycepin producers. This was a qualitative indicating test prior to 
testing for the cordycepin production by the surface liquid culture since a 
quantitative test is not possible here.  
 
2.3.3 Cordycepin production by surface liquid culture using selected mutants 
and control 
 
Figs. 2-4 (a) and (b) show the time courses of the cordycepin production and 
glucose consumption by a surface liquid culture with basal medium using the 
8-azaadenine and 8-azaguanine resistant mutants, respectively. It was observed that 
the cordycepin production performance of mutant nos. A81-2, A81-6, G63-8 and 
G82-4 was lower than that of the control. Mutant nos. A63-7 and A63-8 had a higher 
cordycepin production with a lower metabolic rate than that of the control. In 
contrast, the metabolic rate of glucose as well as the cordycepin production 
performance for mutant no. G81-3 was higher than those of the control. Moreover, 
an intra-strain comparison in 10 consecutive experiments for mutant no. G81-3 also 
showed similar results indicating the stability of the strain regarding its production. 
Regarding the cordycepin production by the surface liquid culture, it was found 
that some of the 8-azaadenine and 8-azaguanine resistant mutants were better 
producers. Generally, the levels of the end products from the biosynthesis are 
regulated by the feedback inhibition, and thus the removal of the feedback cycle 
could lead to an accumulation of the end products. If a mutant can grow in the 
presence of the analogue, 8-azaadenine, the feedback inhibition by adenine-related 
compounds [adenosine monophosphate (AMP), adenosine, adenine] as well as 
8-azaadenine is removed to some extent, and thus the adenine-related compounds 
may be accumulated in the 8-azaadenine-resistant mutant.  
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Fig. 2-4 Time courses of surface liquid culture using (a) 8-azaadenine resistant 
and (b) 8-azaguanine resistant mutants 
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Adenine or adenosine might be a direct precursor of cordycepin as reported in a 
previous study [13], and therefore, the accumulation of adenine or adenosine could 
result in an increased cordycepin production. In the same manner, the 
guanine-related compounds (guanine, guanosine, GMP) might be accumulated in the 
8-azaguanine resistant mutant that could increase the codycepin production, because 
the production of cordycepin and guanine might be related to each other [13]. 
Although the increased production of the end products is due to a variety of reasons, 
the feedback mechanism may be one of the major explainable causes of the 
increased cordycepin production in this experiment. 
The surface liquid culture was selected for this experiment, because the cordycepin 
was suppressed to 1/10~1/13 relative to the surface culture, probably due to shear 
stress [4]. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-5 Time courses of cordycepin production for surface liquid culture of 
mutant no. G81-3 and control in enriched medium 
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[14: 0.35 g/l; 15: 2.2 g/l], although the optimization of our present experiment was 
still in primary level. It is well known that the culture medium is very important to 
the yield of bioactive products like cordycepin because these nutrients are directly 
related to cell division and metabolic biosynthesis. Therefore, further optimization of 
the medium is necessary to obtain the highest production of cordycepin from the said 
mutant no. G81-3. 
 
2.4 Conclusion  
 
In the present experiment, the effects of the mutation induced by a high-energy 
ion beam, which would provide a higher mutation frequency and wider mutation 
spectrum, were studied with the aim of obtaining a higher cordycepin-producing 
mutant of C. militaris. After C. militaris NBRC 9787 was irradiated with a proton 
beam at 800 Gy, an 8-azaguanine-resistant mutant was selected from the irradiated 
strains. As a result, a promising mutant no. G81-3, which showed a better 
performance regarding the metabolic rate of glucose as well as cordycepin 
production than that of the control, was obtained. Preliminary optimization using the 
enriched medium also revealed higher productivity of the mutant no. G81-3 than that 
of the control (cordycepin production as 3.1 g/l vs. 1.8 g/l). As this mutant might 
have a different metabolic property from that of the control, further optimization of 
the medium components is suggested in order to reach a higher level of cordycepin 
production. 
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CHAPTER 3 
Optimization of culture medium for cordycepin production using 
Cordyceps militaris mutant obtained by ion beam irradiation  
 
3.1 Introduction 
 
The medicinal mushrooms are abundant sources of useful natural products with 
various biological activities [1]. Therefore, many researchers in the field of 
physiology, pharmacology and medical science, etc, are interested in the contents of 
mushrooms.       
Among various mushrooms, Cordyceps spp. have been extensively used as the 
crude drug or folk tonic food in East Asia. The Cordyceps genus is a name given to 
the medicinal mushroom that parasitizes in insects and changes itself to fruiting 
bodies, and then comes out of the ground. As it appears like a plant growing out of 
an insect, it is given the self-explanatory name Tochukaso (winter insect-summer 
plant) in Japan. One of the most important species in Cordyceps genus is Cordyceps 
militaris (an entomopathogenic fungus), which belongs to the class Ascomycetes. C. 
militaris contains many kinds of active components, such as cordycepin 
(3′-deoxyadenosine), ergosterol, mannitol and polysaccharides, and due to its various 
physiological activities, is now used for multiple medicinal purposes [2, 3].  
The cordycepin biosynthesized in C. militaris is a unique nucleoside analogue, 
which has a broad spectrum of biological activity, especially as an anti-cancer drug 
[4, 5]. In nature, C. militaris is very scarce due to the requirements of specific hosts 
and strict growth environments. Therefore, a large scale production of cordycepin by 
the cultivation of C. militaris is currently a significant issue.  
To obtain a good productivity, a good strain and an optimized culture condition for 
it are necessary. As for the good producer of cordycepin, we previously reported a 
new approach for obtaining a novel mutant of C. militaris using high-energy ion 
beam irradiation [6]. The obtained mutant, G81-3, had 72% higher cordycepin 
production than that of control in preliminary optimization. As for the culture 
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condition, medium composition, especially carbon and nitrogen sources, is important 
in the yield of any fermentation products [7-10, 11]. However, as far as we know, 
there is limited knowledge about the nutritional requirement for cordycepin 
production by C. militaris, and there have been no reports on medium optimization 
to improve cordycepin production using surface liquid culture. Therefore, in this 
study, the effect of medium components on mutant strain was analyzed using the 
response surface method and the medium components for the cordycepin production 
was optimized.  
 
3.2 Materials and methods 
 
3.2.1 Surface liquid culture of the obtained mutant (G81-3) and control 
 
The methodology of the surface liquid culture for Cordyceps militaris mutant 
(G81-3) and control used in the present experiment is as previously described in 
Chapter 2. The compositions of the basal and enriched media for the surface liquid 
culture are as shown in Table 3-1. 
 
3.2.2 Application of statistical approach for surface liquid culture 
 
3.2.2-1 Experiments on effects of initial carbon (C) and nitrogen (N) levels on 
cordycepin production 
The effects of the initial carbon and nitrogen levels on the surface liquid culture of 
Cordyceps militaris were studied using glucose as the C source and yeast extract 
(Difco Laboratories, USA) as the N source. For investigation of the initial levels of 
the C and N sources for the better cordycepin production, the levels of glucose 
(35.86-128.28; 31.72-88.28 g/l for the mutant and control, respectively) and yeast 
extract (60.86-148.28; 31.72-88.28 g/l for the mutant and control, respectively) in 
the medium (Table 3-3) were changed, and a statistical approach was applied. 
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Table 3-1 Composition of basal & enriched media  
 
              Concentration (g/l) 
Components 
Basal medium Media for optimized condition
Nitrogen sources    
  Peptone 2.5    0  
  Yeast extract 7.5 60.86-148.28 (mutant)  
        31.72-88.28 (control)  
Carbon source    
  Glucose 20 35.86-128.28 (mutant)  
        31.72-88.28 (control)  
Others (diluted to 1/10 concentration of Vogel's medium) 
       (Same for both basal and enriched medium)  
NaOC(COOH)(CH2COONa)2·2H2O 0.28   
KH2PO4 0.5   
NH4NO3 0.2   
MgSO4·7H2O 0.02   
CaCl2·2H2O 0.01   
Citric acid 0.46 × 10−3   
ZnSO4·7H2O 0.50 × 10−3   
Fe(NH4)2(SO4)2·6H2O 0.10 × 10−3   
CuSO4·5H2O 0.025 × 10−3   
H3BO3 5.0 × 10−6   
MnSO4·(4–5)H2O 5.0 × 10−6   
Na2MoO4·2H2O 5.0 × 10−6     
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3.2.2-2 Optimization using Central Composite Design (CCD) 
In order to explore the effect of the medium components (glucose and yeast 
extract) and to optimize them, a statistical approach using the Box-Wilson central 
composite design (CCD) was conducted [12]. The variable levels for the CCD 
experiments were set according to the results of our previous experiments. The CCD 
experimental results were fitted with a second-order polynomial equation of Eq. (1) 
using a multiple regression technique. 
 
y = 0  iix   2iiijiij xxx                         (1)  
 
where y is the predicted response (maximum cordycepin concentration), β 0  is a 
constant coefficient, βi is the linear coefficient, βij is the interaction coefficient, βii  is 
the quadratic coefficient, and xi and xj are the actual values of glucose and yeast 
extract concentrations. 
In this study, the experimental design consisted of 13 trials (1~8: star and factorial 
points, each has 2 replications; 9-13: center points), and the independent variables 
were studied at 5 different levels; as –1.414, –1, 0, +1 and +1.414 (Table 3-2). The 
analysis of variance (ANOVA) was performed to evaluate significance of the model 
and coefficients. This analysis included the Fisher’s F-test (overall model 
significance) with the associated probability p-value, and its statistical significance 
was checked by the F-value. The second order polynomial coefficients were 
calculated and analyzed to have 3D response surface curves. All the above analyses 
were done using “Design Expert” software with the version 7.0 (Stat-Ease Inc., 
USA) statistical package.  
Finally, the surface liquid culture with 7 replications was conducted for validation 
using the predicted concentration (optimized medium) in each culture bottle for both 
the mutant and control, and then the results were averaged. 
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Table 3-2 Experimental design of the central composite design 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.3 Analytical procedures 
 
3.2.3-1 Determination of cordycepin, glucose concentration, dry mycelial weight 
and pH 
The concentrations of cordycepin and glucose, dry mycelial weight and pH were 
measured as previously described in Chapter 2. 
 
3.3 Results and discussion 
 
3.3.1 Optimization of cordycepin production by response surface methodology  
 
Coded levels 
Trial 
X1 X2 
1 +1 +1 
2 –1 +1 
3 +1 –1 
4 –1 –1 
5 –1.414 0 
6 +1.414 0 
7 0 –1.414 
8 0 +1.414 
9 0 0 
10 0 0 
11 0 0 
12 0 0 
13 0 0 
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The combined effect of the carbon source (glucose) and nitrogen source (yeast 
extract) was investigated using CCD, which can help to identify the interaction 
between the variables. The trace element except C and N sources were the same as 
the previous experiments [6, 13, 14]. In our preliminary experiments using CCD, 
that is, the center point was 40 g/l of glucose and 35 g/l of yeast extract and the 
intervals were 10 g/l for both the mutant and the control, the cordycepin productions 
by these strains increased as the glucose and yeast extract concentrations increased. 
The optimal point for the mutant was predicted in higher region than that for the 
control (data not shown). These results could not contradict with the previous report 
showing that the metabolic ability of the mutant was higher than that of the control 
[6].  
Based on the above mentioned result, the CCD experiment shown in Table 3-3 (a-1) 
was first conducted for the mutant, and the predicted concentrations were higher 
than the experimental range. Then, the experimental ranges were shifted to high 
concentrations as shown in Table 3-3 (a-3). The results showed that there was no 
mycelial growth in some culture bottles having a high glucose or yeast extract 
content. Finally, the CCD experiment shown in Table 3-3 (a-2) was conducted to 
complement the range between Table 3-3 (a-1) and (a-3). All the three experiments 
were merged to make a single response surface plot in order to detect the optimized 
medium concentrations along with the prediction of maximum cordycepin 
production. 
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Table 3-3 Coded and actual values of design factors for investigation of medium 
components for the (a) mutant and (b) control 
 
(a-1)     
        Actual factor levels 
Coded levels 
Glucose (x1) Yeast extract (x2)
 -1.414  35.86  60.86 
 -1  40  65 
  0     50  75 
  1  60  85 
   1.414   64.14   89.14 
(a-2)     
        Actual factor levels 
Coded levels 
Glucose (x1) Yeast extract (x2)
 -1.414  36.72  56.72 
 -1  45  65 
  0     65  85 
  1  85  105 
   1.414   93.28   113.28 
(a-3)     
        Actual factor levels 
Coded levels 
Glucose (x1) Yeast extract (x2)
 -1.414  71.72  91.72 
 -1  80  100 
  0     100  120 
  1  120  140 
   1.414   128.28   148.28 
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(b) 
        Actual factor levels 
Coded levels 
Glucose (x1) Yeast extract (x2) 
-1.414 31.72 31.72 
-1 40 40 
0 60 60 
1 80 80 
1.414 88.28 88.28 
 
 
For the control, the predicted medium conditions and cordycepin production were 
obtained from the experiment having a center point concentration of 60 g/l for both 
glucose and yeast extract, with the range from 31.72-88.28 g/l as shown in Table 3-3 
(b). 
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Table 3-4 Results of ANOVA for optimization of medium components [(a) 
mutant and (b) control] 
 
 
 
(b) 
Source Sum of squares df F-value p-value Significance
Model 0.91 5 9.08 <0.0007 significant 
X1: Glucose  0.039 1 1.94 0.1874  
X2: Yeast extract 0.56 1 28.05 0.0001 significant 
X1X2 0.000032 1 0.001592 0.9688  
X12 0.28 1 14.08 0.0024 significant 
X22  0.17 1 8.61 0.0116 significant 
Significant: p<0.05     
 
 
 
 
 
(a)       
Source Sum of squares df F-value p-value Significance
Model   36.97  5  9.99 <0.0001 significant 
X1: Glucose    24.49  1 33.09 <0.0001 significant 
X2: Yeast extract   4.49  1  6.06 0.0184 significant 
X1X2   1.06  1  1.43 0.2387  
X12   10.19  1 13.77 0.0007 significant 
X22     5.73  1  7.75 0.0083 significant 
Significant: p<0.05      
 34
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-1 Response surface plots of cordycepin production as a function of 
glucose and yeast extract concentrations for the (a) mutant and (b) control 
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A regression analysis was performed to fit the response (cordycepin production) 
with the experimental data. Based on the obtained variables, the responses were 
respectively expressed by Eqs. (2) and (3) for the mutant and the control, which 
presented the cordycepin production y (g/l) as a function of the glucose x1 (g/l) and 
yeast extract x2 (g/l) concentrations. 
 
y = –10.14958 + 0.17365x1 + 0.20110x2 – 0.00101x12 – 0.00107x22     (2) (mutant) 
y = –1.37420 + 0.06007x1 + 0.05443x2 – 0.00048x12 – 0.00038x22      (3) (control) 
 
In both cases, there are no interactions between glucose and yeast extract 
concentrations. Results of the analysis of variance (ANOVA) showed that the 
regression model was statistically significant at a 95 % confidence level (p<0.05) 
[Tables 3-4 (a, b); where X is the coded value]. The response surface plots obtained 
from Eqs. (2) and (3) are shown in Figs. 3-1 (a) and (b). The model predicted a 
maximum response of cordycepin of 6.76 g/l at glucose 86.2 g/l and yeast extract 
93.8 g/l for the mutant, and 2.48 g/l at glucose 62.6 g/l and yeast extract 72.5 g/l for 
the control. The optimized concentrations for the mutant was higher than that of the 
control. The cordycepin yield, which was defined as the cordycepin production 
divided by the initial glucose or initial yeast extract concentrations, for the mutant 
were 0.080 g-cordycepin/g-glucose and 0.073 g-cordycepin/g-yeast extract, 
respectively. On the other hand, those for the control were 0.040 
g-cordycepin/g-glucose and 0.034 g-cordycepin/g-yeast extract, respectively. Both 
yields of the mutant are almost double that of the control. Therefore, one of the 
reason for higher production of the mutant was the increase in the yield, i.e., some 
metabolic or catabolic pathway might be deleted or suppressed by ion beam 
irradiation. 
Although the cordycepin production increased with an increase in the glucose or 
yeast extract concentrations to a certain level, the results of our experiment showed 
that a high initial glucose (>100 g/l) or yeast extract (>120 g/l) concentration was 
unfavorable for the cordycepin biosynthesis (data not shown). Here, the osmotic 
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pressure caused by a high glucose concentration may be detrimental to the metabolic 
biosynthesis; although another possible reason is the carbon catabolite repression 
caused by glucose as reported in Saccharomyces cervisiae [15] and Ganoderma 
lucidum [10]. To avoid these negative influences of the high concentrations of 
carbon and nitrogen sources, the fed-batch culture may be effective for higher 
productivities. 
 
3.3.2 Cordycepin production in optimized medium: validation of the model 
 
Validation was carried out under conditions predicted by the model. Figs. 3-2 (a) 
and (b) shows the time profiles of the glucose consumption, pH and cordycepin 
production in the medium with the optimized carbon and nitrogen sources (as 
predicted) for the mutant and the control, respectively. The maximal cordycepin 
production reached 6.84 g/l and 2.45 g/l for the mutant and the control using the 
optimized medium, respectively. These values were almost the same with the 
predicted ones (6.76 g/l for the mutant and 2.48 g/l for the control). It is obvious that 
the cordycepin production by the irradiated mutant is much higher than that of the 
control. That is, the production obtained by the mutant was 179% (2.79 times) higher 
than the control.  
In terms of culture methods of cordycepin production, it is also noteworthy that 
this new mutant showed a lower production in submerged culture than that in the 
surface liquid culture probably due to a shear stress as we previously reported for the 
control [13]. The cordycepin production of this mutant in submerged culture was 
suppressed to about 3% relative to the surface liquid culture; whereas, that of control 
was 80% using optimized media. As is predicted from the observation that the 
mycelial mat of the mutant was weaker than that of the control, the mutant might be 
more sensitive to shear stress. Therefore, the surface liquid culture was employed in 
this experiment. 
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Fig. 3-2 Comparative study of production performance in optimized medium 
for the (a) mutant (G81-3) and (b) control 
 
The biomass concentrations were 2.91 and 2.11 g-dry mycelia/l for the mutant and 
the control, respectively. For mycelial growth, it was revealed that the maximal 
cordycepin production/mycelia at the end of the culture for the mutant was much 
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higher than that of the control (2.35 vs. 1.16 g-cordycepin/g-dry mycelia) furnishing 
an additional proof of a higher cordycepin production by the mutant.  
 
3.4 Conclusion 
In this study, a process of surface liquid culture of C. militaris mutant for the 
production of a bioactive compound, cordycepin, was demonstrated. The effects of 
the major nutrients, i.e., the carbon and nitrogen sources on the cordycepin 
production were studied in order to obtain a suitable culture medium. According to 
the response surface analysis, the optimal concentrations of glucose and yeast 
extract for the mutant strain were 86.2 g/l and 93.8 g/l, respectively, and 6.84 g/l 
cordycepin was obtained. The irradiated mutant showed a 179% higher cordycepin 
production over the control (wild strain). It is necessary to mention that the 
cordycepin production reported by a number of researchers is much lower than that 
of our present study (Table 3-5). Therefore, the obtained mutant will be a promising 
strain for the large-scale production of cordycepin at pharmaco-industrial levels.  
Table 3-5 Cordycepin production using Cordyceps militaris reported by several authors
    
References 
  
Culture method Cordycepin production    Productivity 
     (g/l)                [g/(l·d)] 
Mao & Zhong, 2004 [16] Submerged  0.201                 0.015 
Mao et al., 2005  [17] Submerged  0.345                 0.019 
Mao & Zhong, 2006 [18] Submerged  0.421                 0.025 
Masuda et al., 2006 [13] Surface liquid  0.640                 0.320 
Shih et al., 2006  [19] Submerged & static 2.210                 0.0.92 
Masuda et al., 2007 [14] Surface liquid  2.50                  0.158a 
This study  Surface liquid  6.84 (mutant)           0.190 
      2.45 (control)           0.102b 
The medium compositions of a and b are different. Additives other than C and N sources were used in a.  
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CHAPTER 4  
Further increased productivity of cordycepin by Cordyceps militaris 
mutant using additives and repeated batch operation   
 
4.1 Introduction   
 
It has been a difficult path to find a suitable method to increase the production of 
the anti-cancer agent cordycepin (3′-deoxyadenosine) from the medicinal fungus 
Cordyceps militaris. This novel bio-metabolite cordycepin has a number of valuable 
applications, not only against cancer, but also against some other diseases as 
reported by biotechnologists and medical researchers [1, 2]. In our previous 
experiments, a new mutant of the Cordyceps militaris was obtained using ion beam 
irradiation technology [3]. In the surface culture of that mutant, it was also evident 
that the biosynthesis of cordycepin can be regulated by the concentrations of the 
components used in the culture medium, especially of the C and N sources, and some 
additives that have been investigated in our previous studies [4].  
Adenosine or adenine is one of the end products of purine-metabolic pathway and 
plays an important role as a component of DNA and RNA. In cordycepin production, 
the function of adenine and adenosine were the same, that is, the adenine moiety 
made a contribution to the cordycepin biosynthesis. Although adenine was more 
rapidly transported into the cells than adenosine [4], it was insoluble in higher 
concentrations during medium preparation.  
Similarly, glycine is an amino acid that is used in the purine-metabolic pathway as 
L-glutamine and L-aspartic acid. Although the cordycepin production by glycine and 
L-glutamine were of the same level in our previous study, it was found that the effect 
of glycine was able to be superimposed on that of adenine, but those of adenine and 
L-glutamine did not posses such a property, using a combination of two such 
additives [4]. In addition, research is currently being conducted on the apparent 
anti-oxidant and anti-inflammatory properties of glycine, and it has been found in 
animal studies and could be useful in many disease states like certain cancers acting 
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through metabolic pathways [5, 6]. 
On the other hand, it is well known that the greatest gain in productivity can be 
achieved by a vicious culture system rather than one cycle cell culture technique, as 
the fungal cells grow substantially slower in such a time dependent culture system 
due to lack of required nutrition supply at the end of the each culture cycle. 
Therefore, the conventional culture system is time dependent and usually 
accompanied by a low productivity, whereas, the repeated batch operation is 
independent of time duration, may provide better productivity. 
In a repeated batch culture technique, the un-useful medium is removed at the end 
of each batch and is replenished with a fresh medium having a same medium 
composition. The microbial mat can be used here more than one time. The addition 
of a fresh medium and elimination of an un-useful one at the end of each cycle/batch 
provides the cells with the environment they require actually to achieve a higher 
productivity. 
In our previous experiment, the medium components were optimized for the 
surface culture of the obtained mutant (G81-3) as 86.2 g/l and 93.8 g/l for C & N 
sources, respectively and the relevant peak cordycepin production was 6.84 g/l. In an 
elaborative study to determine the strategies suitable for the extreme production of 
cordycepin using Cordyceps militaris mutant, it was revealed that the effective 
additive compounds for the cordycepin production were glycine, L-aspartic acid, 
L-glutamine, adenine and adenosine [4]. In addition, it was also revealed that the 
application of repeated batch operations had enhanced the productivities to 1.2-1.3 
times higher than those by the batch operations [4]. Therefore, it was of great 
interest to investigate the effects of some additives like adenosine and glycine and 
repeated batch operation on cordycepin production in more detail. 
 
4.2 Materials and Methods 
  
4.2.1 Fungal strain, media and stock culture 
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Cordyceps militaris NBRC 9787 used in the present experiments as the control 
(wild strain) was purchased from the National Institute of Technology and 
Evaluation, Japan, and a prospective mutant of the said strain obtained by ion beam 
irradiation (G81-3) were stored on a PDA (Nissui Pharmaceutical Co., Ltd., Japan) 
slant at 5 °C.  
 
4.2.2 Surface liquid culture using the prospective mutant (G81-3) 
 
The surface liquid culture methodology is as previously described in Chapter 2, 
but the culture was started by inoculating two seed disks (instead of single disk per 
bottle) into a 500 ml culture bottle. All experiments were carried out at least in 
duplicate, and the results were averaged. The compositions of the optimized media 
for the surface liquid culture used in this experiment are shown in Table 4-1. 
 
4.2.3 Experimental design for adenosine and glycine 
 
In the culture medium using previously optimized conditions (Glucose: 86.2 and 
YE: 93.8 g/l) for the said mutant, 2, 4, 6, 8 and 10 g/l adenosine were separately 
added.  
Glycine was used with the yeast extract in weight percent ratios (yeast 
extract/glycine) of 40/60, 50/50, 60/40, 70/30, 80/20 and 90/10 under the condition 
that the total amount of yeast extract and glycine were fixed. Also, glycine was 
separately added as 10, 20 and 30 weight percents of the yeast extract in the culture 
medium having the same optimized conditions with a fixed yeast extract 
concentration. 
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Table 4-1 Composition of optimized media for repeated batch operation 
(mutant and control) 
    
         Concentration (g/l) 
Components 
A. Control B. Mutant   C. Mutant +Adenosine 
Nitrogen sources    
  Yeast extract 72.5  93.8 93.8 
      
Carbon source    
Glucose 62.6 86.2 86.2 
    
Additive    
  Adenosine       6 
Others (diluted to 1/10 concentration of Vogel's medium) 
       (Same for both mutant and the control)  
NaOC(COOH)(CH2COONa)2·2H2O 0.28  
KH2PO4 0.5  
NH4NO3 0.2  
MgSO4·7H2O 0.02  
CaCl2·2H2O 0.01  
Citric acid 0.46 × 10−3  
ZnSO4·7H2O 0.50 × 10−3  
Fe(NH4)2(SO4)2·6H2O 0.10 × 10−3  
CuSO4·5H2O 0.025 × 10−3  
H3BO3 5.0 × 10−6  
MnSO4·(4–5)H2O 5.0 × 10−6  
Na2MoO4·2H2O 5.0 × 10−6   
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4.2.4 Repeated batch operation 
 
A medium exchanging port was placed at the same position as the sampling port in 
the 500 ml surface liquid culture bottle. In addition, the supporter, which was made 
with stainless steel wire (φ=0.3mm) was placed in the bottle in order to prevent the 
biofilm from soaking in the liquid medium. The culture broth replaced with a fresh 
medium through the medium exchanging port using a syringe as soon as the glucose 
concentration tends to zero (glucose conc. <0.5% of the initial conc.) (Figs. 4-1 a, b). 
Three repeated batch operations were conducted simultaneously using the control, 
mutant, and mutant with the best adenosine concentration (6 g/l) attained in the 
preceding experiment and the optimized media were as shown in Table 4-1. 
 
 
 
 
(a) Old Medium drawn                       (b) With a fresh medium 
 
Fig. 4-1 (a, b) Replenishment of culture medium in a repeated batch culture 
 
4.2.5 Preparation of extract from the mycelia of C. militaris  
 
 The cultured mycelia of C. militaris were separated from the medium and 
sufficiently rinsed with distilled water. The mycelia were dried in a vacuum drying 
oven at 40°C for 24 h and then ground into a powder. The dry powder (0.5 g) was 
suspended in 10ml of distilled water and sonicated for 30 min at 20KHz, and 100 W 
(XL2020, Heat System Inc., USA) in an ice bath. The supernatant obtained by 
centrifugation of this homogenate was used as the extract solution from the mycelia.  
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4.2.6 Analytical procedures 
 
The concentrations of cordycepin and glucose, dry mycelial weight and pH were 
measured as previously described in Chapter 2. 
The concentrations of the nucleic acid-related compounds other than cordycepin in 
the filtrate and the extract were also determined by HPLC monitored by UV 
absorbance at 260 nm, which was the same system as previously described in 
Chapter 2. The mobile phase was prepared from the two solvent systems (A, 2.0% 
MeOH in 0.01 M (NH4)H2PO4; B, 20% MeOH in 0.01 M (NH4)H2PO4). After 
solution “A” was used as the mobile phase for 20 min, the linear gradient was 
performed by decreasing the ratio of “A” from 100% to 0% for 10 min. For the next 
10 min, 100% of “B” was used as the mobile phase. The overall elution time was 40 
min. The flow rate was 0.8 ml/min, and the column temperature was 40 °C. The 
authentic standards were purchased from the Wako Pure Chemical Industries, Ltd., 
Japan. 
 
4.3 Results and discussion 
 
4.3.1 Effects of additives  
 
4.3.1-1 Effect of adenosine on cordycepin production 
In the culture medium using the previously optimized conditions (described in 
Chapter 2) for the said mutant, 2, 4, 6, 8 and 10 g/l adenosine were added separately. 
These results revealed that the highest cordycepin production was 8.57 g/l for the 6 
g/l adenosine was 28% higher than that of the control (6.69 g/l) (Figs. 4-3 and 4-4). 
This is the highest cordycepin production reported to date. Similarly, the results of 
the other concentrations also superseded that of the control (Fig. 4-3). The time 
course of glucose showed that the glucose consumption for the 4 g/l adenosine was 
the fastest, while that of 10 g/l was the slowest with the longest culture time among 
all the treatments (Fig. 4-2).  
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Fig. 4-2 Time courses of glucose consumption for surface liquid culture using 
adenosine as an additive 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-3 Time courses of cordycepin concentration for surface liquid culture 
using adenosine as an additive 
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Fig. 4-4 Maximum cordycepin production in surface liquid culture using 
different concentrations of adenosine as an additive 
 
As the structure of the nucleoside adenosine is very close to that of cordycepin 
(3′-deoxyadenosine), there might be a possibility of the metabolic conversion of 
adenosine to cordycepin by an unknown pathway, which needs to be investigated. 
This result is consistent with the findings reported by Masuda et al. [4]. 
 
4.3.1-2 Effect of glycine on cordycepin production 
Glycine was used with yeast extract in weight percent ratios (yeast 
extract/glycine) of 40/60, 50/50, 60/40, 70/30, 80/20 and 90/10 under the condition 
that the total amount of yeast extract and glycine were fixed. Also, glycine was 
separately added as 10, 20 and 30 weight percents of the yeast extract in the culture 
medium having the same optimized conditions with a fixed yeast extract 
concentration. 
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Fig. 4-5 Time courses of glucose consumption for surface liquid culture using 
glycine as an additive (100=93.8 g/l) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-6 Time courses of cordycepin concentration for surface liquid culture 
using glycine as an additive (100=93.8 g/l) 
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Fig. 4-7 Maximum cordycepin production in surface liquid culture using 
different concentrations of glycine as an additive 
 
These results showed that the best cordycepin production was 6.80 g/l for the ratio 
of 90/10 was 12% higher than the control (6.05 g/l) (Figs. 4-6, 4-7). The cordycepin 
production for the ratios 70/30 and 80/20 were also higher than that of the control, 
while the others produced a lower cordycepin amounts compared to that of the 
control, especially the cordycepin production by the 10, 20 and 30 weight percents 
of yeast extract inversely decreased with the glycine concentration (Figs. 4-6, 4-7). 
Regarding the time course, the glucose consumption for the 40/60 ratio was the 
fastest, while for the 30 weight percent yeast extract, it was the slowest with the 
longest culture time among all the treatments (Fig. 4-5). As the cordycepin 
production was lower in case of glycine, a minute investigation is needed to explore 
the constituents of glycine and yeast extract, which might furnish an important clue 
of decreased production. 
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4.3.2 Effects of repeated batch operation  
 
4.3.2-1 Typical batch culture of C. militaris 
 Three repeated batch operations were performed using control and mutant using 
optimized medium for each. In addition, adenosine supplemented medium was used 
for the mutant. The surface of the liquid medium was covered with biofilm by 15 
days for the mutant and 12 days for the control. Figs. 4-8, 4-9 & 4-10 show the 
typical time courses of cordycepin production, glucose, and pH by surface liquid 
culture using optimized medium for the control (wild strain), mutant, and mutant 
with adenosine each.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-8 Typical time course of the surface liquid culture using control  
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Fig. 4-9 Typical time course of the surface liquid culture using mutant G81-3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-10 Typical time course of the surface liquid culture using mutant G81-3 
with adenosine 
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The cordycepin production started slightly after the starting of the cell growth and 
almost stopped when the glucose consumption was finished. When the residual 
glucose reached 0, there was a rise in pH due to autolysis leading to the maximum 
cordycepin production. The production and productivities of cordycepin were 2.33, 
0.16; 5.68, 0.22 and 7.34 g/l, 0.26 g/(l·d) for control, mutant and mutant with 
adenosine in batch operations, respectively (Figs. 4-8, 4-9, & 4-10; Table 4-2). It is 
noteworthy that the present cordycepin productions were somewhat lower than those 
obtained in our previous experiment (Chapter 3, Table 3-5). In fact, cordycepin 
production was calculated in this experiment on the day having the highest 
productivity in each case in contrast to that of the control (Table 4-2), which is 
practically a few days before reaching the production peak level.  
 
 
4.3.2-2 Repeated batch culture of control, mutant and mutant with adenosine 
using optimized media 
For a further increase in cordycepin production, the feasibility of the repeated 
batch operation was examined. In our present technique, steel wires with special nets 
were used to replenish the medium without causing any harm to the surface biofilm. 
The glucose consumption was used as a criterion for the exchange of medium. Figs. 
4-11 (a), 4-12 (a) and 4-13 (a) show the time courses of the cordycepin production 
and Figs. 4-11 (b), 4-12 (b) and 4-13 (b) show the glucose concentrations and pH of 
the control, mutant and mutant with adenosine, respectively, when an optimized 
medium was used for each.  
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Fig. 4-11 (a) Time courses of the cordycepin production of repeated batch 
operation using control  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-11 (b) Time courses of the glucose concentration and pH of repeated 
batch operation using control  
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Fig. 4-12 (a) Time courses of the cordycepin production of repeated batch 
operation using mutant  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-12 (b) Time courses of the glucose concentration and pH of repeated 
batch operation using mutant  
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Fig. 4-13 (a) Time courses of the cordycepin production of repeated batch 
operation using mutant with adenosine  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-13 (b) Time courses of the glucose concentration and pH of repeated 
batch operation using mutant with adenosine 
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In every case of repeated batch culture using control, mutant, and mutant with 
adenosine, the better production that was not less than the initial level was 
maintained up to the third cycle and later, they showed lower cordycepin productions 
as the whole operation was continued for five cycles/batches. On the medium 
exchanging day, sampling for both the last day of the succeeding batch and first day 
(0 day) for the preceding batch were done and between them the cordycepin 
production was considered as zero. As we mentioned about the mycelial autolysis, it 
is quite possible to prevent the mycelia from autolysis by the repeated batch 
operation resulting in an increased production and productivity. The productivity 
was calculated as the total cordycepin production (g/l) divided by the total time 
period needed for that. To have the highest productivity, this period is considered up 
to the day of the last batch after the glucose concentration became below 0.5% of the 
initial concentration (Table 4-2).  
The results of cordycepin production and productivities of control, mutant and 
mutant with adenosine per batch calculated from the all sum of all the batches were 
summarized in Table 4-2. The productivities of the repeated batches were 34%, 86% 
and 82% higher than those of batches for control, mutant and mutant with adenosine, 
respectively; whereas, those of mutant and mutant with adenosine were 113% and 
131% higher than that of the control, respectively. Also, productivity of mutant with 
adenosine was 9% higher than that of the mutant in repeated batch culture. 
Additionally, the productivities of batch operations of mutant and mutant with 
adenosine were 53% and 70% higher than that of the control. Hence, the 
effectiveness of the repeated batch operation is obvious in both the cases of mutant 
and control.  
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Table 4-2 Comparison of cordycepin productivity in batch and repeated batch 
cultures 
 
Control Mutant 
Culture types A. Optimized 
medium 
B. Optimized 
medium 
 
C. Optimized 
medium 
+ 
Adenosine 
Batch      
Period (d) 15 24 24-30 
Production 
(g/l) 
 2.33  5.68 7.34 
Productivity 
[g/(l·d)] 
  0.155  0.237 0.263 
    
Repeated batch     
Period (d)  42b 51a 51a 
Production a 
(g/l) 
    8.677b  22.50a 24.43a 
Productivity 
[g/(l·d)] 
    0.207b   0.441a  0.479a 
     a Five batches, b Three batches 
 
Although the production of repeated batch culture was higher than that of the 
batch culture, in a close investigation, it was observed that some parts of the mycelia 
did not touch the replenished fresh medium. It might be one of the major explainable 
causes (Fig. 4-14 a) for not reaching the production a further higher level. As the 
culture continued for a long time, the mycelia became curvy; also somewhere it sunk 
into the medium and some parts became cracked, these facts may be considered for 
decreased production of cordycepin (Figs. 4-14 b, c & d). 
In this experiment, it was revealed that the application of repeated batch operation 
could increase the production and productivity significantly in contrast to the batch 
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operation. Therefore, this technique will be applicable for industrial production of 
cordycepin for future uses, leading to develop a continuous production protocol. 
These results are entirely consistent with previous work of our laboratory [4]. It is 
also mentionable that it could reduce the labour, time and energy. 
 
 
 
 
 
 
 
 
(a) Untouched mycelia                   (b) Curved mycelia 
 
 
 
 
 
 
 
 
(c) Sunk mycelia                         (d) Cracked mycelia 
 
Fig. 4-14 Photographs of untouched, curved, sunk and cracked mycelia in 
repeated batch operation 
 
4.3.2-3 Nucleic acid-related compounds 
The contents of nucleic acid-related compounds in the extract from the mycelia 
and the filtrate of medium by the batch operation for the mutant and the control are 
summarized bellow in Table 4-3.  
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Table 4-3 Nucleic acid-related compounds obtained from C. militaris 
 
Contents Extract from mycelia 
(mg) 
Filtrate of medium 
(mg) 
C. militaris 
NBRC 9787 (18d) 
  
Mycelia      3.29×104  
Adenine 2.9   2.8 
Guanine 18.5 175.2 
Uracil 37.1 105.0 
Adenosine 91.1  52.6 
Guanosine 78.7  47.1 
Uridine 106.8  81.1 
Cordycepin 56.2       2.5×103 
   
C. militaris 
G81-3 (24d) 
  
Mycelia       3.87×104  
Adenine 1.6   5.1 
Guanine 23.2 271.7 
Uracil 29.2 185.2 
Adenosine 45.4 132.0 
Guanosine 41.3  97.8 
Uridine 45.4 122.6 
Cordycepin 129.7       4.5×103 
All values were estimated on the basis of a working volume of 1L. 
 
Analyzing the results, it is evident that major portion of cordycepin existed in the 
medium, that is, the synthesized cordycepin was immediately excreted in the 
medium. This is consistent with the results reported by Masuda et al. [4]. In case of 
 61
the control, it was found that the concentrations of adenosine and guanosine decrease 
as the cordycepin concentration increase. On the other hand, in case of the mutant, 
the concentrations of adenosine and guanosine increase with an increase of 
cordycepin concentration. This result suggests that the production of cordycepin 
using mutant is linked to either adenosine and/or guanosine in the medium. 
 
4.3.2-4 Measurement of dry mycelial weight  
In a comparison of dry mycelial weight, it was found that in every case of mutant, 
regardless of culture technique, the dry mycelial weight was higher than that of the 
control. Table 4-4 summarized the comparison of dry mycelial weight of mutant and 
the control. 
 
Table 4-4 Comparison of dry mycelial weight of mutant and the control  
 
Control  Mutant  
Culture types 
 
A. 
Optimized 
medium 
 
B. Optimized 
medium 
C. Optimized 
medium 
+ 
Adenosine 
Batch       
Period (d) 18  36 36 
Dry mycelial weight 
(g/l) 
  32.9  35.0  33.6 
     
Repeated batch      
Period (d) 72  51 51 
Dry mycelial weight 
(g/l) 
113.2 
 
126.5 130.2 
 
It is evident that the dry mycelial weight of mutant is always accompanied by a 
higher cordycepin productivity showing a positive relationship with each other. 
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4.4 Conclusion  
 
The results of the present experiments suggested that the additives had positive 
influences on cordycepin production in which the adenosine had a much better 
influence than that of glycine. It is necessary to mention that the cordycepin 
production reported by a number of authors [2, 4, 7-10] is much lower than that of 
our present research study (8.57 g/l). In this experiment, it was also evident that a 
higher concentration of both the adenosine and glycine negatively affected the 
cordycepin production.  
Furthermore, the repeated batch operation presently investigated was also 
significantly effective in increasing the productivity of cordycepin as well as a 
continuous production protocol for industrial uses. In a course of searching a suitable 
culture technique, the repeated batch operations of control, mutant, and mutant with 
adenosine with an optimized medium for each were used. The cordycepin 
productivities of batches and repeated batches were 0.16, 0.20; 0.24, 0.44 and 0.26 
g/l, 0.48 g/(l•d) for control, mutant, and mutant with adenosine, respectively. In fact, 
the productivities of the repeated batches were 34%, 86% and 82% higher than those 
of batches for control, mutant and mutant with adenosine, respectively; whereas, 
those of mutant and mutant with adenosine were 113% and 131% higher than that of 
the control, respectively. The nucleic acid-related compounds analysis revealed that 
the adenosine and guanosine were somehow linked to cordycepin production in case 
of mutant. Therefore, the mutant (G81-3) obtained by the proton beam irradiation 
with the best adenosine concentration (8.57 g/l) might be an effective combination 
for repeated batch operation in optimized medium to achieve a further higher 
cordycepin productivity. The present research will also provide valuable information 
for mushroom researchers, cancer and radiation biologists, chemical engineers, 
biotechnologists, medical practitioners, and personnel in the pharmaceutical 
industries. 
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CHAPTER 5  
General conclusion 
 
5.1 Achievements 
 
  The author minutely investigated the different techniques that might be used for 
higher production of the potential anti-cancer agent cordycepin from the medicinal 
mushroom Cordyceps militaris to be used in the realm of pharmaco-industrial 
biotechnology. Mutation by ion beam irradiation (carbon and proton), medium 
optimization, use of suitable additives and finally repeated batch operations are the 
salient tools in this regard.  
Chapter 2 describes a novel approach to obtain a prospective Cordyeps militaris 
mutant for higher cordycepin production using high-energy ion beam irradiation. 
Carbon beam irradiation revealed a little change in their growth rate, however, a 
higher production of cordycepin compared to the control was not accomplished. 
Following the successful proton beam irradiation, 30 classes of 8-azaadenine- and 28 
classes of 8-azaaguanine-resistant mutants were obtained, of which 7 classes (A63-7, 
A63-8, A81-2, A81-6, G63-8, G81-3, G82-4) were selected as initially promising 
mutants using their antibacterial ability as an index of the cordycepin production. 
Results of a surface liquid culture revealed that the cordycepin production ability of 
mutant nos. A81-2, A81-6, G63-8 and G82-4 was lower than that of the control. 
Mutant nos. A63-7 and A63-8 had a higher cordycepin production with a lower 
metabolic rate than that of the control. On the other hand, mutant no. G81-3 was 
higher than that of the control regarding the metabolic rate of glucose as well as the 
cordycepin production ability. Therefore, for primary optimization using enriched 
medium, G81-3 was selected as a promising one that had 72 % higher cordycepin 
production than that of the control (3.1 vs. 1.8 g/l).  
In Chapter 3, the optimization of medium components was depicted for the culture 
of Cordyceps militaris mutant obtained by ion beam irradiation. According to the 
response surface analysis using a central composite design the predicted maximum 
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response of cordycepin production was 6.76 g/l at glucose 86.2 g/l and yeast extract 
93.8 g/l for the mutant no. G81-3, and 2.48 g/l at glucose 62.6 g/l and yeast extract 
72.5 g/l for the control. The cordycepin production of the mutant was 2.79 times 
higher than that of the control. Validation was carried out under conditions predicted 
by the model that revealed a close correlation between the predicted and 
experimental values (6.84 and 2.45 g/l for mutant and control, respectively).  
Chapter 4 describes the strategies for a further higher cordycepin production by 
employing the additives influenced biosynthesis of cordycepin and repeated batch 
operation using Cordyceps militaris mutant. In the culture medium under the 
previously optimized conditions for the said mutant, 2, 4, 6, 8 and 10 g/l adenosine 
were separately added. These results revealed the highest cordycepin production of 
8.57 g/l when using 6 g/l adenosine was 28% higher than that of the control (6.69 
g/l). This is the highest report of cordycepin production until now. Similarly, the 
results of other concentrations also superseded the control. For the same purpose, 
glycine was used with yeast extract in weight percent ratios (yeast extract/glycine) of 
40/60, 50/50, 60/40, 70/30, 80/20 and 90/10 under the condition that the total 
amount of yeast extract and glycine were fixed. Also, glycine was separately added 
as 10, 20 and 30 weight percents of the yeast extract in the culture medium having 
the same optimized conditions with a fixed yeast extract concentration. These results 
showed that the 90/10 ratio had the best cordycepin production of 6.80 g/l that was 
12% higher versus the control (6.05 g/l). The cordycepin production of the 70/30 and 
80/20 weight percent ratios were also higher than that of the control, while the others 
had a lower cordycepin production compared to that of the control. Although, 
adenosine had a much better influence than glycine, it was also evident that a higher 
concentration of both adenosine and glycine negatively affected the cordycepin 
production. Later on, the repeated batch culture operations using optimized 
conditions for control, mutant and mutant with the best adenosine concentration (6 
g/l) were performed in order to have a further higher cordycepin productivity for 
industrial uses. The cordycepin productivities of batches and repeated batches were 
0.16, 0.20; 0.24, 0.44 and 0.26 g/l, 0.48 g/( l•d ) for control, mutant and mutant with 
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adenosine, respectively. In fact, the productivities of the repeated batches were 34%, 
86% and 82% higher than those of batches for control, mutant and mutant with 
adenosine, respectively; whereas, those of mutant and mutant with adenosine were 
113% and 131% higher than that of the control, respectively. Also, productivity of 
mutant with adenosine was 9% higher than that of the mutant in repeated batch 
culture. Additionally, the productivities of batch operations of mutant and mutant 
with adenosine were 53% and 70% higher than that of the control. Hence, the 
effectiveness of the repeated batch operation is obvious in both the cases of mutant 
and control.   
 
5.2 Future perspectives   
 
Nature is the source of all the raw materials that we need. About 2-3 decades ago, 
most of the drugs were of herbal origin. A variety of reasons remain behind why 
people like to use natural medicines as it is evident that patients are getting even 
more distressed after using the chemically synthesized drugs, rather than natural 
means like medicinal mushrooms that can conquer life-claiming diseases, leaving no 
side effects on human health. To maintain proper growth, the pharmaceutical 
industries need innovation and access to high output rate on low-cost materials with 
reasonable safety. The combination of modern chemistry with bio-based starting 
materials, like bio-metabolites, offers the scope for revolutionizing mushroom based 
pharmaceutical industries. In the near future, bio-metabolites (cordycepin, 
polysaccharides etc.) extracted from medicinal mushroom like C. militaris will have 
a role that compares with that of oil and gas crackers today.  
The ancient medicinal fungus C. militaris, which has been used as a crude drug 
for the welfare of mankind in old civilization, is now of a matter of concern due to 
its unexplored potentials. The anti-cancer agent cordycepin obtained from C. 
militaris have more than 21 clinically approved beneficial effects for human health. 
Especially, the anti-cancer agent cordycepin from C. militaris is expected to play 
evolutionary roles in the pharmacognosy sector, leading to create a viable base for 
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pharmaceutical industries as some emerging diseases like CANCER, SARS, AIDS, 
SWINE FLU have no proper remedies yet. In this regard, it needs further elaborative 
pharmacological investigation and clinical trials.  
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